Last reviewed · How we verify
Comparative Study Between Dexmedetomidine and Nalbuphine as Analgesic Adjuvants to Bupivacaine in Superficial Cervical Block for Patients Undergoing Anterior Cervical Discectomy and Fusion (ACDF) Surgery A Double Blinded Randomized Trial
Anterior cervical discectomy and fusion (ACDF) nowadays is considered a common procedure.postoperative pain can hinder recovery and prolong hospital stay. The superficial cervical plexus block (SCPB) is a safe and simple technique that had been found to allow good pain relief in neck surgeries. The main drawback of SCPB was short duration, so adjuvants as dexmedetomidine and opioids has been used to increase analgesic duration and decrease the use of opioids. The current study will compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to bupivacaine in SCPB in anterior cervical fusion surgeries.
Details
| Lead sponsor | Kasr El Aini Hospital |
|---|---|
| Phase | Phase 4 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 30 |
| Start date | 2024-07 |
| Completion | 2024-11 |
Conditions
- Anterior Cervical Discectomy and Fusion (ACDF)
Interventions
- Dexmedetomidine in superficial cervical plexus block
- Nalbuphine in superficial cervical plexus block
Primary outcomes
- The total nalbuphine consumption in mg — The 1st 48 hours starting after patient transfer to the PACU.
The total nalbuphine consumption measured in mg during the 1st 48 hours postoperatively starting after patient transfer to the PACU.